Abstract
Hypoparathyroidism is the most common endocrine disorder detected in patients with autoimmune polyendocrine syndrome type 1 (APS-1); however, a parathyroid-specific autoantibody has not yet been identified. Alimohammadi et al. have screened a human parathyroid complementary DNA library with serum samples from patients with APS-1 and detected NACHT leucine-rich-repeat protein 5 (NALP5) immunoreactivity in 49% of patients with APS-1-associated hypoparathyroidism. When measured with a novel fluid-phase radioimmunoassay, these autoantibodies were found to be highly specific for the hypoparathyroid component of APS-1. In addition, NALP5 was predominantly expressed in the parathyroid gland. In this Practice Point commentary, I discuss the mechanistic and diagnostic implications of this finding for patients with APS-1. The natural history of NALP5 autoantibody expression in relation to the development of hypoparathyroidism is currently unclear. Furthermore, the positive and negative predictive value of NALP5 autoantibodies for the prediction of hypoparathyroidism among patients with APS-1 still needs to be defined.
References
Perheentupa J (2006) Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 91: 2843–2850
Villaseñor J et al. (2005) AIRE and APECED: molecular insights into an autoimmune disease. Immunol Rev 204: 156–164
Taubert R et al. (2007) Highly variable expression of tissue-restricted self-antigens in human thymus: implications for self-tolerance and autoimmunity. Eur J Immunol 37: 838–848
Meager A et al. (2006) Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3: e289
Alimohammadi M et al. (2008) Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 358: 1018–1028
Wenzlauv JM et al. (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 104: 17040–17045
Eisenbarth SC et al. (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122–1126
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Eisenbarth, G. Do NALP5 antibodies correlate with hypoparathyroidism in patients with APS-1?. Nat Rev Endocrinol 4, 544–545 (2008). https://doi.org/10.1038/ncpendmet0924
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0924
- Springer Nature Limited
This article is cited by
-
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy
Journal of Clinical Immunology (2015)